Search the Newsreel

Why Quest Diagnostics Stock Climbed This Past Week

Profusa (PFSA) pursues diagnostics acquisition and plans $7M convertible financing

Profusa (PFSA) has signed a non-binding term sheet to acquire a commercial-stage health diagnostics and toxicology testing company, whose 2025 net revenues are estimated at $111 million. Concurrently, Profusa plans to raise approximately $7 million through a subordinated convertible note. The company also announced …

HireQuest's Q2 results call will be broadcast live Aug. 10

Aquestive Therapeutics Inc (AQST) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Aquestive Therapeutics Inc (AQST) focusing on its dividend and stock split history. It notes that the company has not distributed any dividends in the past five years. The page also presents current stock performance data, including market cap …

Aquestive Therapeutics Inc (AQST) Income Statement

This article provides a detailed quarterly and annual income statement for Aquestive Therapeutics Inc (AQST), allowing investors to analyze the company's financial performance and operational efficiency. It presents data spanning several fiscal years, covering metrics such as total revenue, operating expenses, net income, and …

Quest Diagnostics (DGX) Leads S&P 500 Healthcare Gainers with 8.15% Increase

Quest Diagnostics (DGX) was the top gainer in the S&P 500 Health Care Index Sector on July 26, 2026, with an 8.15% increase, despite a mixed market. The company, a leading diagnostic testing provider, has a P/E ratio of 24.19x and a GF Score …

Hirequest Inc (HQI) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides a historical overview of dividend payouts and stock splits for Hirequest Inc (HQI). It details the interim and final cash dividends distributed by HQI, including their record dates, payment dates, and ex-dividend dates, spanning a period from 2023 to 2026. Over …

Why Quest Diagnostics (DGX) Is Up 8.2% After Raising 2026 Guidance And Boosting Buybacks

Quest Diagnostics (DGX) Stock Gets Fair Value Boost After Q2 Beat And Higher Guidance

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Quest Diagnostics is back in focus after analysts lifted Fair Value estimates from US$223.44 to US$239.38, a move that has coincided with price …

Quest Diagnostics Incorporated Revenue Breakdown – NYSE:DGX

This article provides a revenue breakdown for Quest Diagnostics Incorporated (NYSE:DGX). Last year, the company generated $11.04 billion USD in revenue, with the Diagnostic Information Services segment contributing the majority at $10.79 billion USD. The United States was the primary geographical contributor, accounting for …

HireQuest, Inc. Revenue Breakdown – NASDAQ:HQI

HireQuest, Inc. (NASDAQ: HQI) generated $30.64 million USD in revenue last year, with its HireQuest Direct segment contributing the most at $13.98 million USD. All of the company's revenue ($30.64 million USD) came from the United States.

HQI|Hirequest Inc|Price:12.900|Chg%:+0.220

Hirequest Inc (HQI) is currently trading at $12.90, showing a 1.74% increase. The company's fundamentals are considered healthy with high growth potential, and its valuation is deemed fairly valued within the Professional & Commercial Services industry. Analysts rate HQI as a Strong Buy with …

Quest Diagnostics Incorporated Stock 12‑Month Price Target Raised to $241.73, Implies 6% Upside

Quest Diagnostics Incorporated's average price target has been increased from $239.47 to $241.73 by 15 analysts, suggesting a 6% potential upside from its July 23 closing price. The consensus rating remains "Buy" with 10 Buys and 11 Holds among 21 covering analysts.

QRHC|Quest Resource Holding Corp|Price:1.250|

Quest Resource Holding Corp (QRHC) shows strong fundamentals and high growth potential, with its stock currently considered fairly valued. Analysts have a "Buy" rating with a target price indicating significant upside, despite recent stock price stagnation. The company specializes in waste and recycling services, …

Quest Diagnostics Inc (DGX) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Quest Diagnostics Inc (DGX), highlighting its current earnings forecast score of 7.50, ranking 41st in its industry. Analysts have an average price target of $198.00 for DGX, with most recommending a "Buy" trend. The article also details …

QRHC|Quest Resource Holding Corp|Price:1.282|Chg%:+0.032

Quest Resource Holding Corp (QRHC) is a provider of waste and recycling services, offering customer-specific programs for various waste streams across multiple industries. The company also provides detailed transactional and environmental results of its services. Key financial information and executive details are provided, along …

QUEST DIAGNOSTICS INC : TRUIST SECURITIES RAISES TARGET PRICE TO $250 FROM $225

TRUIST SECURITIES has increased its target price for QUEST DIAGNOSTICS INC (DGX.N) to $250, up from the previous $225. This adjustment reflects an updated outlook on the company's financial prospects. The article, sourced from Reuters, reports on this change in analyst rating.

Quest Diagnostics Incorporated (DGX) Soars to 52-Week High, Time to Cash Out?

A strong stock as of late has been Quest Diagnostics (DGX). Shares have been marching higher, with the stock up 10.5% over the past month. The stock hit a new 52-week high of $237.78 in the previous session. Quest Diagnostics has gained 31.3% since …

Is Quest Diagnostics (DGX) Stock Still Worth More Than Its Price?

Quest Resource Holding Corporation to Report Second Quarter 2026 Financial Results and Host Earnings Call on August 6, 2026

Quest Resource Holding Corporation (QRHC) will release its second-quarter 2026 financial results on August 6, 2026, after market close. Management will host a conference call on the same day at 5:00 PM ET to discuss the results and business outlook. Investors can participate via …

Quest to discuss waste and recycling services on Aug. 6

Quest Resource Holding Corporation (Nasdaq: QRHC) announced it will release its second-quarter 2026 financial results after market close on Thursday, August 6, 2026. Management will host an earnings conference call on the same day at 5:00 PM ET to discuss the results and business …

ETFs Investing in Aquestive Therapeutics, Inc. Stocks

This article lists various ETFs that include Aquestive Therapeutics, Inc. (AQST) stocks in their holdings. It provides detailed financial data for each ETF, such as market value, weight of AQST in the fund, issuer, management style, expense ratio, AUM, price, change percentage, relative volume, …

Quest Diagnostics projects $11.95B-$12.05B 2026 revenue while raising EPS outlook again

Earnings Call Insights: Quest Diagnostics (DGX) Q2 2026 MANAGEMENT VIEW * "Our strong performance in the second quarter demonstrates focused execution of our strategy to connect people and providers to innovative testing and actionable insights... In the quarter, we grew revenues by over 10%... …

Quest Diagnostics Stock Gains As Oncology Moves Impress Wall Street

Quest Diagnostics (DGX) shares rose by 7.52% following strong earnings and increased full-year guidance, driven significantly by advancements in its oncology division. The New York State Department of Health's clearance of Quest's Haystack MRD ctDNA liquid biopsy test for minimal residual disease detection, enabling …

Lockheed Martin, Quest Diagnostics, Thermo Fisher Scientific And Other Big Stocks Moving Higher On Thursd

Several large-cap stocks, including Lockheed Martin, Quest Diagnostics, and Thermo Fisher Scientific, are experiencing significant gains on Thursday after reporting better-than-expected quarterly financial results and, in many cases, raising their full-year guidance. Lockheed Martin reported strong earnings and sales, leading to an 11.4% jump …

Quest Diagnostics Surges After Hims- And Oura-Tied Beat

Quest Diagnostics put up a definitive beat Thursday, driven by solid demand across its consumer division, leading the stock to surge. Continue Reading

Quest Diagnostics stock hits all-time high at 227.31 USD By Investing.com

Quest Diagnostics (DGX) stock achieved an all-time high of $227.31, with shares currently trading at $232, reflecting a 22.07% increase over the past year. The company has consistently raised its dividend for 14 consecutive years and recently surpassed analyst expectations for its second-quarter results …

DGX Stock Up on Q2 Earnings & Revenue Beat, '26 View Raised

Quest Diagnostics (DGX) reported a notable beat on both Q2 2026 earnings and revenue, with adjusted earnings per share up 19.1% year over year and revenues rising 10.2%. This strong performance, driven by increased testing demand, led the company to raise its full-year 2026 …

Quest Diagnostics Releases Q2 2026 Financial Results

Quest Diagnostics Incorporated exceeded Wall Street expectations for its second-quarter 2026 results, reporting adjusted earnings of $3.12 per share against an estimated $2.85, and revenue of $3.04 billion, a 10.2% increase from Q2 2025. The company benefited from strong demand for laboratory services and …

Quest Diagnostics raises full-year guidance after Q2 revenue rises 10.2%

Quest Diagnostics reported strong Q2 2026 financial results, with net revenue increasing by 10.2% to $3.043 billion and adjusted diluted EPS rising 19.1% to $3.12, both surpassing analyst estimates. Attributing the growth to execution across various channels and sustained demand, the company raised its …

Earnings Flash (DGX) Quest Diagnostics Incorporated Reports Q2 Revenue $3.04B, vs. FactSet Est of $2.97B

Quest Diagnostics Incorporated (DGX) reported Q2 revenue of $3.04 billion, surpassing FactSet's estimate of $2.97 billion. This financial news indicates a stronger-than-expected performance for the diagnostic testing and information services provider in the second quarter of 2026. Earlier, the company also announced Q2 adjusted …

Earnings Flash (DGX) Quest Diagnostics Incorporated Posts Q2 Adjusted EPS $3.12 per Share, vs. FactSet Est of $2.82

Quest Diagnostics Incorporated (DGX) reported Q2 adjusted EPS of $3.12 per share, exceeding the FactSet estimate of $2.82. The company also announced Q2 revenue of $3.04 billion, surpassing FactSet's estimate of $2.97 billion, and expects full-year 2026 revenue between $11.95 billion and $12.05 billion.

Quest Diagnostics stock rises 5% on strong Q2 beat, raised guidance

Quest Diagnostics (NYSE:DGX) reported strong second-quarter results, surpassing analyst expectations for both EPS and revenue. The company also raised its full-year 2026 guidance for both revenue and adjusted EPS, leading to a nearly 5% rise in pre-market trading. This performance was attributed to robust …

Quest Diagnostics climbs as Q2 earnings top estimates, guidance raised (DGX:NYSE)

Quest Diagnostics (DGX) shares rose by approximately 11% after the company announced second-quarter earnings that exceeded Wall Street's expectations. The diagnostic testing company also raised its full-year 2026 guidance above consensus. Adjusted earnings per share for the quarter were reported at $3.12, surpassing estimates.

QUEST DIAGNOSTICS ($DGX) Releases Q2 2026 Earnings | DGX Stock News

Quest Diagnostics Q2 Earnings Call Highlights

Quest Diagnostics Incorporated Q2 2026 Earnings Call Summary - Moby Strategic Performance Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. Revenue …